Alterity Therapeutics annual debt-to-equity ratio
2019
2020
2021
2022
2026
Alterity Therapeutics Debt-to-Equity Ratio Growth & History (ATHE)
Alterity Therapeutics's debt-to-equity ratio was 0.00 for fiscal 2026.
View full Alterity Therapeutics company overviewAlterity Therapeutics annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-06-30 | 0.00 | — | — |
| 2022 | 2022-06-30 | 0.00 | 0.00 | +53.75% |
| 2021 | 2021-06-30 | 0.00 | −0.00 | −54.35% |
| 2020 | 2020-06-30 | 0.00 | −0.00 | −28.01% |
| 2019 | 2019-06-30 | 0.01 | — | — |
Alterity Therapeutics quarterly debt-to-equity ratio
Q4.19
Q4.20
Q4.21
Q4.22
Q2.25
Q2.26
Q4.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-06-30 | 0.00 | — | — |
| Q2 2026 | 2025-12-31 | 0.00 | −0.01 | −86.65% |
| Q2 2025 | 2024-12-31 | 0.01 | — | — |
| Q4 2022 | 2022-06-30 | 0.00 | 0.00 | +53.75% |
| Q4 2021 | 2021-06-30 | 0.00 | −0.00 | −54.35% |
| Q4 2020 | 2020-06-30 | 0.00 | −0.00 | −28.01% |
| Q4 2019 | 2019-06-30 | 0.01 | — | — |
Alterity Therapeutics debt-to-equity ratio trends
Over the last five fiscal years, Alterity Therapeutics's debt-to-equity ratio increased from 0.00 to 0.00, a change of 0.00. The latest reported quarter, Q4 2026, shows 0.00.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Alterity Therapeutics source filings ↗